Zobrazeno 1 - 10
of 44
pro vyhledávání: '"C, Kosloff"'
Autor:
Charlotte Cunningham-Rundles, Elizabeth M. Smithwick, Robert A. Good, Susanna Cunningham-Rundles, Frederick P. Siegal, Sudhir Gupta, C. Kosloff
Publikováno v:
Journal of Clinical Immunology. 1:65-72
Mononuclear cells from 39 patients with hypogammaglobulinemia of the common variable type were analyzed for in vitro proliferative response to a panel of cell activators in order to examine the lymphocyte response to mitogens and to study the capacit
Autor:
Elizabeth M. Smithwick, Robert A. Good, Susanna Cunningham-Rundles, C. Cunni Ngham‐Rundles, Frederick P. Siegal, D. I. Ma, C. Kosloff, Sudhir Gupta
Publikováno v:
Scandinavian Journal of Immunology. 15:279-286
The cell-mediated immune responses of 39 patients with common variable immunodeficiency (CVI) were studied in vitro, using Staphylococcus aureus and Escherichia coli prepared as whole cells and Candida albicans extract. These microbial activators wee
Publikováno v:
Cancer. 47(10)
One hundred and sixty-five cases of malignant schwannoma were reviewed. Sixty-five (40%) of the patients had evidence of disseminated neurofibromatosis. Patients with neurofibromatosis were younger, had malignant schwannomas that were centrally rathe
Publikováno v:
National Cancer Institute monograph. (56)
Fifty-nine patients under 21 years of age with embryonal rhabdomyosarcoma were treated according to a multidisciplinary protocol (T-2). The protocol consisted of surgical removal of the tumor, if possible, determination of clinicopathologic stages of
Autor:
G, Rosen, A, Nirenberg, B, Caparros, H, Juergens, C, Kosloff, B M, Mehta, R C, Marcove, A G, Huvos
Publikováno v:
National Cancer Institute monograph. (56)
Sixty-one patients were treated with combination chemotherapy (T-7) for biopsy-proved, fully malignant, osteogenic sarcoma (OS) of the extremity. Chemotherapy consisted of the combination of bleomycin, cyclophosphamide, and dactinomycin, followed in
Publikováno v:
Cancer treatment reports. 66(2)
Seventy-four patients with non-small cell lung cancer were treated in a prospective, randomized trial either with a four-drug combination of cisplatin, doxorubicin, cyclophosphamide, and vindesine (PACE) or with a three-drug combination of cisplatin,
Autor:
D P, Kelsen, R, Ahuja, S, Hopfan, M S, Bains, C, Kosloff, N, Martini, P, McCormack, R B, Golbey
Publikováno v:
Cancer. 48(1)
One hundred ten patients with epidermoid carcinoma of the esophagus were treated at the Memorial Sloan-Kettering Cancer Center (MSKCC) with combined modality techniques involving preoperative irradiation (RT) and surgery, and with preoperative chemot
Publikováno v:
National Cancer Institute monograph. (56)
Twenty-eight previously untreated patients with embryonal rhabdomyosarcoma, stages II to IV, were treated with the T-6 induction protocol and maintained on the T-2 protocol. The T-6 protocol consisted of simultaneous administration of drugs and irrad
Autor:
G, Rosen, B, Caparros, A, Nirenberg, R C, Marcove, A G, Huvos, C, Kosloff, J, Lane, M L, Murphy
Publikováno v:
Cancer. 47(9)
Since May 1970, 67 consecutive patients with primary (nonmetastatic) Ewing's sarcoma were treated with adjuvant chemotherapy (CT) in addition to radiation therapy (RT) or surgery for the primary tumor. The first 19 patients were treated with four-dru
Publikováno v:
National Cancer Institute monograph. (56)
Forty-three patients, ranging in age from 7 to 30 years (median age, 17 yr), with primary osteogenic sarcoma (OS), confirmed by biopsies and with no evidence of metastatic disease at the time of diagnosis, received T-7 chemotherapy for an average of